SGLT2 inhibitors and mortality in diabetic cancer patients: cardioprotective and anticancer effects is a research paper published in European Heart Journal - Cardiovascular Pharmacotherapy (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1RF1AG069121
National Institutes of Health
Grant: 1R01HL156518
National Institutes of Health
Grant: 1R01AG073474
Department of Veterans Affairs
Grant: I01HX002422
Department of Veterans Affairs
Grant: 1I01HX003552
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals